Corvus Pharmaceuticals Files 8-K
Ticker: CRVS · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1626971
| Field | Detail |
|---|---|
| Company | Corvus Pharmaceuticals, Inc. (CRVS) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, corporate-filing
TL;DR
Corvus Pharma filed an 8-K on 6/4/25 covering disclosures and financials.
AI Summary
Corvus Pharmaceuticals, Inc. filed an 8-K on June 4, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 901 Gateway Boulevard, Third Floor, South San Francisco, California, 94080, with a phone number of (650) 900-4520.
Why It Matters
This 8-K filing provides an update on Corvus Pharmaceuticals' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- Corvus Pharmaceuticals, Inc. (company) — Registrant
- June 4, 2025 (date) — Date of earliest event reported
- 901 Gateway Boulevard, Third Floor, South San Francisco, California, 94080 (location) — Address of principal executive offices
- (650) 900-4520 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Corvus Pharmaceuticals, Inc.?
The primary purpose is to report on events including a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, as of June 4, 2025.
Where are Corvus Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 901 Gateway Boulevard, Third Floor, South San Francisco, California, 94080.
What is the telephone number for Corvus Pharmaceuticals, Inc.?
The telephone number is (650) 900-4520.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 4, 2025.
What is the state of incorporation for Corvus Pharmaceuticals, Inc.?
The state of incorporation is Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Corvus Pharmaceuticals, Inc. (CRVS).